Notes are for nuclei/CMO; however, for cells/LMO the protocol is the basically the same but using 0.04% BSA because BSA sequesters LMOs (See Multi-Seq paper, McGinnis et al., Nat Med, 2019).
You may scale up or down LMO/CMO concentrations while maintaining the same ratio LMO/CMO per cell/nuclei used in paper.
-For LMOs/CMOs on live cells that's 8 pmol/100K or 40 pmol/500K, in a reaction volume of 200 uL, which gives you 40 nM (100K cells) and 200 nM (500K cell), respectively.
-For LMOs/CMOs on nuclei they seem to have used 500 uM (500K nuclei), that is 100 pmol/500K, in (likely) a reaction volume of 200 uL, so it'll be 20 pmol/100K nuclei (this is 2.5 times higher than for lives cells). We have used CMOs at 200 nM in a 200 uL reaction and works fine. Both version will be given in the step-by-step protocol, but the one inferred from paper (using 500 nM) will be [in between brakets and italized].
-I would recommend to determine what's the optimal amount of CMO or LMO/number of cells or nuclei in your hands. For GM12878 cell line I used 200 nM for nuclei and managed to get very good libraries. You may also want to test 200 nM versus 500 nM and see which is best for your sample. From Supplementary Figure 1, panels A and C, 200 nM seems to be enough.
-We have also replaced polyA for Capture sequence 2 (Feature), libraries look very good as well. This was done to avoid competition between CMO/LMOs and endogenous RNAs for polyA oligos.
5'-CCTTGGCACCCGAGAATTCCAXXXXXXXXGCTCACCTATTAGCGGCTAAGG-3'